Yottar | $1,000,000 | (Aug 28, 2025)
EnsiliTech | $6,058,064 | (Aug 28, 2025)
Sequifi | $6,700,000 | (Aug 28, 2025)
Certified by Founder
Lodge
Bolden Therapeutics
start up
United States
- Providence, Rhode Island
- 10/01/2024
- Unknown
- Undisclosed Amount
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.
- Industry Biotechnology Research
- Website https://www.boldentherapeutics.com/
- LinkedIn https://www.linkedin.com/company/bolden-therapeutics/about/
Bench IQ | $5,300,000 | (Aug 28, 2025)
Heave | $7,000,000 | (Aug 28, 2025)
Aurelian | $14,000,000 | (Aug 28, 2025)
InstaLILY AI | $25,000,000 | (Aug 28, 2025)
Matiks | $3,100,000 | (Aug 28, 2025)
Vox AI | $8,738,305 | (Aug 28, 2025)
Artificial Societies | $5,350,000 | (Aug 28, 2025)
Aurasell AI | $30,000,000 | (Aug 27, 2025)